comparemela.com
Home
Live Updates
Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023 : comparemela.com
Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023
Overall sensitivity of early cancer detection for novel blood-based assay was 82% at 95% specificity; specific cancer detection rates include colo...
Related Keywords
Chicago ,
Illinois ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
American ,
Franziska Michor ,
Stephenm Hahn ,
Twitter ,
Dana Farber Cancer Institute ,
Harbinger Health ,
Prnewswire Harbinger Health ,
Regenerative Biology At Harvard University ,
Linkedin ,
Department Of Data Science ,
American Society Of Clinical Oncology ,
Sarah Cannon Research Institute ,
Department Of Biostatistics ,
Department Of Stem Cell ,
Sarah Cannon Research ,
Meeting Proceedings ,
Clinical Oncology ,
Annual Meeting Proceedings ,
Professor Franziska Michor ,
Computational Biology ,
Data Science ,
Public Health ,
Stem Cell ,
Regenerative Biology ,
Cancer Origin Epigenetics ,
Flagship Pioneering ,
comparemela.com © 2020. All Rights Reserved.